Literature DB >> 11006234

Localization of MYOC transcripts in human eye and optic nerve by in situ hybridization.

R E Swiderski1, J L Ross, J H Fingert, A F Clark, W L Alward, E M Stone, V C Sheffield.   

Abstract

PURPOSE: To evaluate MYOC (myocilin) gene expression at the RNA level in normal intact human eyes and optic nerve using in situ hybridization.
METHODS: Normal human eyes and optic nerves from donors 62 to 83 years of age with no history of glaucoma were fixed, embedded in paraffin, and sectioned. Sections were hybridized with (35)S-labeled sense and antisense riboprobes derived from a full-length MYOC cDNA.
RESULTS: High levels of MYOC expression were observed throughout the trabecular meshwork as well as in the most anterior nonfiltering meshwork (Schwalbe's line), in the scleral spur, and in the endothelial lining of Schlemm's canal. MYOC transcripts were also detected in the anterior corneal stroma, in the ciliary muscle, beneath the anterior border of the iris, in the iris stroma, and in the sclera. Expression in the retrolaminar region of the optic nerve was present in the pial septa that divide the nerve fiber bundles, in the perivascular connective tissue surrounding the central retinal vessels, and in the dura mater, arachnoid, and pia mater of the meningeal sheath surrounding the optic nerve.
CONCLUSIONS: MYOC gene expression in the trabecular meshwork, Schlemm's canal, scleral spur, and ciliary muscle indicates a structural or functional role for myocilin in the regulation of aqueous humor outflow that may influence intraocular pressure. MYOC expression in the optic nerve suggests that changes in the structural, metabolic, or neurotropic support of the optic nerve may influence its susceptibility to glaucomatous damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006234

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  29 in total

1.  Evidence for a novel glaucoma locus at chromosome 3p21-22.

Authors:  Paul N Baird; Simon J Foote; David A Mackey; Jamie Craig; Terence P Speed; Alexandre Bureau
Journal:  Hum Genet       Date:  2005-05-20       Impact factor: 4.132

2.  Aggregated myocilin induces russell bodies and causes apoptosis: implications for the pathogenesis of myocilin-caused primary open-angle glaucoma.

Authors:  Gary Hin-Fai Yam; Katarina Gaplovska-Kysela; Christian Zuber; Jürgen Roth
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 3.  Glaucoma genetics.

Authors:  Pratap Challa
Journal:  Int Ophthalmol Clin       Date:  2008

Review 4.  Glaucoma-associated myocilin: a better understanding but much more to learn.

Authors:  Zachary T Resch; Michael P Fautsch
Journal:  Exp Eye Res       Date:  2008-08-29       Impact factor: 3.467

Review 5.  ER stress and unfolded protein response in ocular health and disease.

Authors:  Heike Kroeger; Wei-Chieh Chiang; Julia Felden; Amanda Nguyen; Jonathan H Lin
Journal:  FEBS J       Date:  2018-06-20       Impact factor: 5.542

6.  Transgenic mice expressing mutated Tyr437His human myocilin develop progressive loss of retinal ganglion cell electrical responsiveness and axonopathy with normal iop.

Authors:  Tsung-Han Chou; Stanislav Tomarev; Vittorio Porciatti
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-14       Impact factor: 4.799

7.  Contributions of mouse genetic background and age on anterior lens capsule thickness.

Authors:  Brian P Danysh; Kirk J Czymmek; Pecos T Olurin; Jacob G Sivak; Melinda K Duncan
Journal:  Anat Rec (Hoboken)       Date:  2008-12       Impact factor: 2.064

8.  Myocilin is a modulator of Wnt signaling.

Authors:  Heung-Sun Kwon; Hee-Sheung Lee; Yun Ji; Jeffrey S Rubin; Stanislav I Tomarev
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

9.  BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells.

Authors:  Jin-Zhong Zhang; Megan E Cavet; Karl R VanderMeid; Mercedes Salvador-Silva; Francisco J López; Keith W Ward
Journal:  Mol Vis       Date:  2009-12-08       Impact factor: 2.367

10.  RNA interference as a gene silencing therapy for mutant MYOC protein in primary open angle glaucoma.

Authors:  Mao Li; Jianjiang Xu; Xueli Chen; Xinghuai Sun
Journal:  Diagn Pathol       Date:  2009-12-16       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.